CHRISTAL JOSEPH: Open Payments
NPI 1396031472 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 40 payments from 11 companies in 2025. Trend: 2023 $914 · 2024 $576 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $64 |
| HARMONY BIOSCIENCES LLC | 3 | $59 |
| Electromed, Inc. | 7 | $52 |
| JAZZ PHARMACEUTICALS INC. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 1 | $32 |
| Amgen Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| GENZYME CORPORATION | 1 | $17 |
Products named: NUCALA, TRELEGY ELLIPTA, WAKIX, SMARTVEST, XYWAV, FASENRA, DUPIXENT, PURIFIED CORTROPHIN GEL.
Industry payments across TX — which companies pay providers there.
